Paul J. Tiseo
Directeur Technique/Scientifique/R&D chez COGNITION THERAPEUTICS, INC.
Postes actifs de Paul J. Tiseo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COGNITION THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 11/10/2022 | - |
Historique de carrière de Paul J. Tiseo
Anciens postes connus de Paul J. Tiseo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Formation de Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Paul J. Tiseo
- Expérience
